In the TNFAIP2 high expression nasopharyngeal carcinoma specimen group, 40.5% of patients developed distant metastasis; this proportion was only 12.1% in the TNFAIP2 low expression group. The gene discussed is TNFAIP2; the disease is nasopharyngeal carcinoma.